CoChat

Bone morphogenic protein 3 inactivation is an early and frequent event in colorectal cancer development

Loh, Kim, Chia, June A., Greco, Sonia, Cozzi, Sarah‐Jane, Buttenshaw, Ron L., Bond, Catherine E., Simms, Lisa A., Pike, Tanya, Young, Joanne P., Jass, Jeremy R., Spring, Kevin J., Leggett, Barbara A., Whitehall, Vicki L. J. · 2008 · Genes, Chromosomes and Cancer
Cited by 97

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

Bone morphogenic proteins (BMPs) are members of the TGFB growth factor superfamily with well‐described functions in bone formation. Although disrupted BMP signalling in tumor development has more recently been investigated, a role for BMP3 in colorectal cancer (CRC) has remained largely unexplored. The aim of this study was to investigate BMP3 disruption in CRCs in relation to both the traditional and serrated pathways of tumor progression. BMP3 was down‐regulated as assessed by real‐time PCR in 50 of 56 primary tumors (89%). Bisulfite sequencing of the putative promoter revealed extensive hypermethylation in the cell line HT29, in which expression could be restored by treatment with a methyltransferase inhibitor. Aberrant hypermethylation was observed in 33/60 (55%) tumors and was highly correlated with microsatellite instability (P < 0.01), the CpG Island Methylator Phenotype (P < 0.01), BRAF oncogene mutation (P < 0.01), and proximal location (P < 0.001). Methylation was also frequently observed in serrated and traditional adenomatous polyps (22/29, 76%). Re‐introduction of BMP3 into cell lines revealed marked growth suppression supporting the functional relevance of this alteration in colorectal tumor development. This study provides molecular and functional data supporting the importance of BMP3 silencing as an early and frequent event in colorectal tumors progressing via the serrated and traditional pathways. © 2008 Wiley‐Liss, Inc.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/gcc.20552

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Cited by

See all 97

Metadata

Authors
Loh, K., Chia, J. A., Greco, S., Cozzi, S., Buttenshaw, R. L., Bond, C. E., Simms, L. A., Pike, T., Young, J. P., Jass, J. R., Spring, K. J., Leggett, B. A., & Whitehall, V. L. J.
Venue
Genes, Chromosomes and Cancer
Publisher
Wiley
Published
2008-02-29
Volume
47
Issue
6
Pages
449-460
ISSN
  • 1045-2257 (ISSN-L)
  • 1098-2264
OpenAlex
W2156898371
Cited by
97
References
1
FWCI
4.63
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Bone morphogenic protein 3 inactivation is an early and frequent event in colorectal cancer development. https://app.cochat.ai/papers/10.1002/gcc.20552
The paper
Loh, K., Chia, J. A., Greco, S., Cozzi, S., Buttenshaw, R. L., Bond, C. E., Simms, L. A., Pike, T., Young, J. P., Jass, J. R., Spring, K. J., Leggett, B. A., & Whitehall, V. L. J. (2008). Bone morphogenic protein 3 inactivation is an early and frequent event in colorectal cancer development. Genes, Chromosomes and Cancer. https://doi.org/10.1002/gcc.20552

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.